Literature DB >> 22128325

Computerized method for automatic evaluation of lean body mass from PET/CT: comparison with predictive equations.

Tao Chan1.   

Abstract

UNLABELLED: CT has become an established method for calculating body composition, but it requires data from the whole body, which are not typically obtained in routine PET/CT examinations. A computerized scheme that evaluates whole-body lean body mass (LBM) based on CT data from limited-whole-body coverage was developed. The LBM so obtained was compared with results from conventional predictive equations.
METHODS: LBM can be obtained automatically from limited-whole-body CT data by 3 means: quantification of body composition from CT images in the limited-whole-body scan, based on thresholding of CT attenuation; determination of the range of coverage based on a characteristic trend of changing composition across different levels and pattern recognition of specific features at strategic positions; and estimation of the LBM of the whole body on the basis of a predetermined relationship between proportion of fat mass and extent of coverage. This scheme was validated using 18 whole-body PET/CT examinations truncated at different lengths to emulate limited-whole-body data. LBM was also calculated using predictive equations that had been reported for use in SUV normalization.
RESULTS: LBM derived from limited-whole-body data using the proposed method correlated strongly with LBM derived from whole-body CT data, with correlation coefficients ranging from 0.991 (shorter coverage) to 0.998 (longer coverage) and SEMs of LBM ranging from 0.14 to 0.33 kg. These were more accurate than results from different predictive equations, which ranged in correlation coefficient from 0.635 to 0.970 and in SEM from 0.64 to 2.40 kg.
CONCLUSION: LBM of the whole body could be automatically estimated from CT data of limited-whole-body coverage typically acquired in PET/CT examinations. This estimation allows more accurate and consistent quantification of metabolic activity of tumors based on LBM-normalized standardized uptake value.

Entities:  

Mesh:

Year:  2011        PMID: 22128325     DOI: 10.2967/jnumed.111.089292

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  6 in total

1.  Usefulness of standardized uptake value normalized by individual CT-based lean body mass in application of PET response criteria in solid tumors (PERCIST).

Authors:  Atsushi Narita; Susumu Shiomi; Yutaka Katayama; Takashi Yamanaga; Hiromitsu Daisaki; Kazuo Hamada; Yasuyoshi Watanabe
Journal:  Radiol Phys Technol       Date:  2016-02-12

Review 2.  Current status and future role of brain PET/MRI in clinical and research settings.

Authors:  P Werner; H Barthel; A Drzezga; O Sabri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-09       Impact factor: 9.236

3.  Direct Determination of Lean Body Mass by CT in F-18 FDG PET/CT Studies: Comparison with Estimates Using Predictive Equations.

Authors:  Chang Guhn Kim; Woo Hyoung Kim; Myoung Hyoun Kim; Dae-Weung Kim
Journal:  Nucl Med Mol Imaging       Date:  2013-05-07

4.  Pharmacokinetic analysis of [18F]FAZA in non-small cell lung cancer patients.

Authors:  Eline E Verwer; Floris H P van Velden; Idris Bahce; Maqsood Yaqub; Robert C Schuit; Albert D Windhorst; Pieter Raijmakers; Adriaan A Lammertsma; Egbert F Smit; Ronald Boellaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-06-06       Impact factor: 9.236

5.  Evaluation of SUVlean consistency in FDG and PSMA PET/MR with Dixon-, James-, and Janma-based lean body mass correction.

Authors:  Jun Zhao; Qiaoyi Xue; Xing Chen; Zhiwen You; Zhe Wang; Jianmin Yuan; Hui Liu; Lingzhi Hu
Journal:  EJNMMI Phys       Date:  2021-02-17

6.  Rapid Standardized CT-Based Method to Determine Lean Body Mass SUV for PET-A Significant Improvement Over Prediction Equations.

Authors:  Terence A Riauka; Vickie E Baracos; Rebecca Reif; Freimut D Juengling; Don M Robinson; Marguerite Wieler; Alexander J B McEwan
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.